Mercury Laboratories Ltd
₹749.00▼ -6.00 (-0.79%)
MERCURYLAB·BSE·Healthcare
Market Cap
89.48 Cr
PE Ratio
18.59
Volume
34
Day High - Low
749.00 - 745.00
52W High-Low
928.50 - 620.55
₹749.00▼ -6.00 (-0.79%)
Market Cap89.48 Cr
PE Ratio18.59
Volume34
Day High - Low749.00 - 745.00
52W High-Low928.50 - 620.55
Mercury Laboratories Ltd (MERCURYLAB): company summary
The company's annual revenue grew 1.1% to ₹76 crore, while annual net profit surged 53.8% to ₹5 crore.
Mercury Laboratories Ltd (MERCURYLAB) is a micro-cap Healthcare company valued at ₹89 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Mercury Laboratories Ltd last traded at ₹749, modestly down 0.79% on the day.
- Recent developments
- On 2026-09-30, promoter holding remained at 73.66%, showing no change in ownership. The latest quarter results, ending 2026-06-30, revealed a sharp decline in net profit, which contrasts with the strong annual net profit growth.
- Financial performance
- The company's annual revenue grew 1.1% to ₹76 crore, while annual net profit surged 53.8% to ₹5 crore. However, the latest quarter saw revenue drop 12.0% year-on-year to ₹16 crore and net profit fall 69.1% to ₹0 crore, indicating a recent slowdown in profitability.
- Valuation multiples
- The stock trades at 18.6 times earnings, a discount to the Healthcare median of 32.0, 1.65 times book value. It yields 0.4%.
- Things to watch
- The latest quarter net profit fell to ₹0 crore, a significant drop from ₹1 crore in the prior quarter. The stock is 18.7% below its 52-week high, and the 3-year profit CAGR of -4.7% suggests declining profitability over time.
- Where it stands
- Mercury Laboratories Ltd ended the latest quarter with zero net profit, despite a 53.8% annual net profit increase. The stock is 18.7% below its 52-week high, and the company's profit growth has slowed over the past three years.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
8.32%
Average
P/E
18.59x
Fair
Debt / Equity
0.15
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹745.00
₹749.00
52W₹620.55
₹928.50
DocStoX take
Supported by risk (8.6), but held back by growth (1.3). Risk looks strong at 8.6, but that is offset by growth at 1.3. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.3
/10
Weak
Quality
Modest
ROE 8.3%
Valuation
Rich
P/E 18.6×
Growth
Flat
Revenue +2.0% 5Y CAGR
Risk
Low risk
D/E 0.15
Momentum
Soft
42% of 52-week range
At a glance
Market Cap
₹89 Cr
52W High / Low
₹929 / ₹621
Dividend Yield
0.44%
Promoter Holding
73.66%
EPS (TTM)
₹40.28
Book Value
₹483.97
Key highlights
- Low leverage — D/E 0.15
- Profitable in all of the last 5 years
- Profit shrinking 2% a year
- Growth is weak (1.3/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Mercury Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Mercury Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LLAURUS LABS LIMITEDZYDUS LIFESCIENCES LTDAPOLLO HOSPITALS ENTER. LCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare Mercury Laboratories Ltd with peers
Mercury Laboratories Ltd vs SUN PHARMACEUTICAL IND LMercury Laboratories Ltd vs DIVI S LABORATORIES LTDMercury Laboratories Ltd vs TORRENT PHARMACEUTICALS LMercury Laboratories Ltd vs LAURUS LABS LIMITEDMercury Laboratories Ltd vs ZYDUS LIFESCIENCES LTDMercury Laboratories Ltd vs APOLLO HOSPITALS ENTER. L
Related tools & concepts
Value Mercury Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing